Nucleus Software Exports Limited
NUCLEUS · NSE · Technology
With a 20% margin of safety, our buy-below price is ₹625.51.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%13.6%
- ✓Low debt (D/E < 0.5)0.01x
- ✓Positive free cash flow
- ✕Revenue growth > 10%-2%
- ✕Earnings growing-47%
- ✓Net margin ≥ 10%13.3%
- ✓Current ratio > 1.52.09
- ✓Below our fair value
- ✕Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 5.23
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Analyst views
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 5.23.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Trading in our value buy zone versus sector peers.
Threats
- •Earnings contracting year on year.
About Nucleus Software Exports Limited
Nucleus Software Exports Limited provides lending and transaction banking products to the financial services industry in India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally. Its flagship products include FinnOne Neo, a lending solution designed to support retail, corporate, and Islamic sectors for banks and other financial service companies; and FinnAxia, an integrated transaction banking solution comprising global receivables
More in Technology
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.